iBio (IBIO) Return on Capital Employed (2016 - 2025)
iBio (IBIO) has disclosed Return on Capital Employed for 15 consecutive years, with 0.44% as the latest value for Q4 2025.
- Quarterly Return on Capital Employed rose 41.0% to 0.44% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.44% through Dec 2025, up 41.0% year-over-year, with the annual reading at 0.94% for FY2025, 40.0% down from the prior year.
- Return on Capital Employed for Q4 2025 was 0.44% at iBio, up from 0.54% in the prior quarter.
- The five-year high for Return on Capital Employed was 0.18% in Q1 2021, with the low at 1.45% in Q4 2023.
- Average Return on Capital Employed over 5 years is 0.74%, with a median of 0.61% recorded in 2024.
- The sharpest move saw Return on Capital Employed tumbled -109bps in 2023, then skyrocketed 95bps in 2024.
- Over 5 years, Return on Capital Employed stood at 0.23% in 2021, then tumbled by -282bps to 0.88% in 2022, then plummeted by -65bps to 1.45% in 2023, then soared by 42bps to 0.85% in 2024, then surged by 48bps to 0.44% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.44%, 0.54%, and 1.24% for Q4 2025, Q3 2025, and Q2 2025 respectively.